Literature DB >> 15530877

In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration.

Thomas Debeir1, M Marien, J Ferrario, P Rizk, A Prigent, F Colpaert, R Raisman-Vozari.   

Abstract

We have previously reported that the alpha2-adrenoceptor antagonist dexefaroxan protects against the degeneration of nucleus basalis magnocellularis (NbM) cholinergic neurons following cortical devascularization in the adult rat. Since nerve growth factor (NGF) is critical to the survival of NbM cholinergic neurons in the adult brain and its synthesis is known to be regulated by noradrenergic mechanisms, we examined whether the protective effect of dexefaroxan in the devascularization model was associated with regional induction of NGF biosynthesis. Dexefaroxan or vehicle was administered to rats via subcutaneous minipumps for 28 days following devascularization or sham operation procedures. In vehicle-treated devascularized rats, NGF protein levels in the cortex were increased at 5 days but had normalized by 2 weeks postoperation; NGF levels in NbM remained unchanged during this time. In dexefaroxan-treated devascularized rats, increases in NGF protein levels (2-fold) and immunoreactivity were maintained in both the cortex and NbM over the entire 28-day postoperation period; these increases were coincident with changes in functional markers characteristic of NGF's actions, including increases in choline acetyltransferase (ChAT), p75 and TrkA immunoreactivities, and a preservation of NbM cholinergic cell numbers. Dexefaroxan also increased NGF protein levels in sham-operated rats, but without any significant consequence to the otherwise normal NbM cholinergic phenotype in these animals. Results indicate that activation of endogenous NGF systems could contribute to the cholinergic protective effect of dexefaroxan in the cortical devascularization model, and provide further support for a potential therapeutic utility of dexefaroxan in neurodegenerative diseases where central cholinergic function is progressively compromised.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530877     DOI: 10.1016/j.expneurol.2004.08.023

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand.

Authors:  Lane K Bekar; Helen S Wei; Maiken Nedergaard
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-08       Impact factor: 6.200

2.  Herpes Simplex Virus Type 1 Preferentially Enhances Neuro-Inflammation and Senescence in Brainstem of Female Mice.

Authors:  Mahesh Kumar Sivasubramanian; Raisa Monteiro; Kelly S Harrison; Bhuvana Plakkot; Madhan Subramanian; Clinton Jones
Journal:  J Virol       Date:  2022-08-17       Impact factor: 6.549

3.  Increasing CNS noradrenaline reduces EAE severity.

Authors:  Maria Vittoria Simonini; Paul E Polak; Anthony Sharp; Susan McGuire; Elena Galea; Douglas L Feinstein
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-04       Impact factor: 4.147

4.  The locus coeruleus neurotoxin, DSP4, and/or a high sugar diet induce behavioral and biochemical alterations in wild-type mice consistent with Alzheimers related pathology.

Authors:  Pooja Choudhary; Anthony G Pacholko; Josh Palaschuk; Lane K Bekar
Journal:  Metab Brain Dis       Date:  2018-06-03       Impact factor: 3.584

5.  Neuroprotective, Neurogenic, and Amyloid Beta Reducing Effect of a Novel Alpha 2-Adrenoblocker, Mesedin, on Astroglia and Neuronal Progenitors upon Hypoxia and Glutamate Exposure.

Authors:  Magda M Melkonyan; Lilit Hunanyan; Ali Lourhmati; Nikolas Layer; Sandra Beer-Hammer; Konstantin Yenkoyan; Matthias Schwab; Lusine Danielyan
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

6.  Impaired Phasic Discharge of Locus Coeruleus Neurons Based on Persistent High Tonic Discharge-A New Hypothesis With Potential Implications for Neurodegenerative Diseases.

Authors:  Kathrin Janitzky
Journal:  Front Neurol       Date:  2020-05-12       Impact factor: 4.003

7.  Effects of Manipulation of Noradrenergic Activities on the Expression of Dopaminergic Phenotypes in Aged Rat Brains.

Authors:  Fei Zeng; Yan Fan; Russell W Brown; Wesley Drew Gill; Jennifer B Price; Thomas C Jones; Meng-Yang Zhu
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

Review 8.  Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease.

Authors:  Eoin O'Neill; Andrew Harkin
Journal:  Neural Regen Res       Date:  2018-08       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.